Table 1.
Variable | Result |
Borderline RHD (N=170) | |
Age (years), median (IQR) | 14 (11–16) |
Female gender, N (%) | 111 (65.7) |
Follow-up period (months), mean±SD | 28.9 ± 9.0 |
At least two morphological features of RHD of the MV without pathological MR or MS | 5 (2.9) |
Pathological MR | 135 (79.4) |
Pathological AR | 30 (17.6) |
Definite RHD (N=27) | |
Age (years), median (IQR) | 14.0 (12–16) |
Female gender, N (%) | 19 (70.4) |
Follow-up period (months), mean±SD | 29.5±9.2 |
Pathological MR and at least two morphological features of RHD of the MV | 24 (88.9) |
MS mean gradient ≥4 mm Hg | 0 |
Pathological AR and at least two morphological features of RHD of the AV | 0 |
Borderline disease of both the AV and MV | 3 (11.1) |
AR, aortic regurgitation; AV, aortic valve; MR, mitral regurgitation; MS, mitral stenosis; MV, mitral valve; RHD, rheumatic heart disease.